GPER1 and neuroendocrine neoplasm: Among the large panel of neuroendocrine tumours investigated, distinct differences in GPER expression were observed depending on the localisation of the tumour entities, with the highest proportion of positive cases and the highest average IRS values observed for tumours of the pancreas compared with tumours from other sites.